Highly rated in
Highly rated in
Check Dr. Pamela T. Soliman's experience treating your condition:
About Dr. Pamela T. Soliman

Pamela Soliman is a Gynecologic Oncologist and an Oncologist in Houston, Texas. Soliman has been practicing medicine for over 24 years and is highly rated in 22 conditions, according to our data. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Pseudomyxoma Peritonei, Hysterectomy, and Oophorectomy. She is licensed to treat patients in Texas. Soliman is currently accepting new patients.

Her clinical research consists of co-authoring 130 peer reviewed articles and participating in 15 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Pamela T. Soliman it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Pamela T. Soliman accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Community Health
1515 Holcombe Blvd, Houston, TX 77030
Background & Education
Graduate Institution
Virginia Commonwealth University, School Of Medicine, 1999
Gynecologic Oncology
Obstetrics & Gynecology in TX
Hospital Affiliations
University Of Texas MD Anderson Cancer Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
A Phase II, Randomized Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (LEE011) in Patients With Advanced or Recurrent Endometrial Carcinoma
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Prospective Evaluation of Lymph Node Metastasis at the Time of Surgical Staging for High Risk Endometrial Cancer
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Prospective Evaluation of Robot-Assisted Surgery in Gynecologic Oncology
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
View 7 Less Clinical Trials -

130 Total Publications

Update on MRI in Evaluation and Treatment of Endometrial Cancer.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors